Allscripts (MDRX) Reports In-Line Q4 EPS

Allscripts (NASDAQ: MDRX) reported Q4 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $343 million versus the consensus estimate of $358.1 million.

Bookings(1) in the fourth quarter were $244 million compared with $274 million in the fourth quarter of 2013, an 11% decline. Fourth quarter 2014 bookings reflect double-digit growth in ambulatory solutions, managed IT services, and international sales compared with the fourth quarter of 2013. Partially offsetting this growth was a decline in client demand for patient portal solutions, a requirement for meeting Meaningful Use 2 (MU2). This demand positively impacted bookings results during the second half of 2013 as well as the first half of 2014.

Allscripts sees FY2015 EPS of $0.42-$0.50, versus the consensus of $0.47. Allscripts sees FY2015 revenue of $1.43-1.46 billion, versus the consensus of $1.48 billion.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• C.H. Robinson acquires DeSpir Logistics for $75 million
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits